• Order to parcel locker

    Order to parcel locker
  • easy pay

    easy pay
  • Reduced price
  • New
Chronic Lymphocytic Leukemia, An Issue of Hematology/Oncology Clinics of North America

Chronic Lymphocytic Leukemia, An Issue of Hematology/Oncology Clinics of North America

9780443345470
514.03 zł
436.93 zł Save 77.10 zł Tax included
Lowest price within 30 days before promotion: 436.93 zł
Quantity
Available in 4-6 weeks

  Delivery policy

Choose Paczkomat Inpost, Orlen Paczka, DHL, DPD or Poczta Polska. Click for more details

  Security policy

Pay with a quick bank transfer, payment card or cash on delivery. Click for more details

  Return policy

If you are a consumer, you can return the goods within 14 days. Click for more details

Description
In this issue of Hematology/Oncology Clinics, guest editors Drs. Jennifer R. Brown and Matthew S. Davids bring their considerable expertise to the topic of Chronic Lymphocytic Leukemia. Top experts provide in-depth perspectives on CLL, including basic biology, frontline and relapsed refractory treatments, mechanisms of resistance to targeted therapies, Richter’s transformation, and some of the common complications of the disease stemming from immune dysfunction-offering a state-of-the-art overview of the field to help optimize the care of patients with CLL.
Product Details
Elsevier
103697
9780443345470
9780443345470

Data sheet

Publication date
2025
Issue number
1
Cover
hard cover
Pages count
240
Dimensions (mm)
152 x 229
Weight (g)
450
  • Autonomous B-cell Receptor Signaling in Chronic Lymphocytic Leukemia
    The Chronic Lymphocytic Leukemia Epigenome: A Powerful and Stable Framework for Understanding Biological and Clinical Heterogeneity
    Frontline Treatment of Chronic Lymphocytic Leukemia with Continuous Bruton’s Tyrosine Kinase Inhibitors: A Comprehensive Overview
    First-line Therapy: Time-Limited Venetoclax Doublet Therapy
    Triplet Therapies in Chronic Lymphocytic Leukemia
    Measurable/Minimal Residual Disease: What Method and What Cut-Off?
    Management of Relapsed and/or Refractory Chronic Lymphocytic Leukemia
    Resistance to Bruton Tyrosine Kinase Inhibitors
    Understanding and Targeting BCL2-inhibitor Resistance in Chronic Lymphocytic Leukemia
    Immunotherapy in Chronic Lymphocytic Leukemia
    Advances in the Understanding of Richter Transformation
    Autoimmune Cytopenias in Chronic Lymphocytic Leukemia
    Understanding and Managing Infectious Complications in Chronic Lymphocytic Leukemia
Comments (0)